Reflow Medical announced that the Medical University of Graz enrolled the first patient in its DEEPER CHALLENGE clinical trial. This marks an early clinical-stage milestone, typically supportive for the program’s progress, though it is not yet indicative of efficacy or commercial timelines.
Reflow Medical announced that the Medical University of Graz enrolled the first patient in its DEEPER CHALLENGE clinical trial. This marks an early clinical-stage milestone, typically supportive for the program’s progress, though it is not yet indicative of efficacy or commercial timelines.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15